Current Japanese clinical practice involves the usage of large amounts of new macrolides such as clarithromycin and roxithromycin for the treatment of diffuse panbronchiolitis, Helicobacter pylori and Mycobacterium avium complex infections. In this study, the phenotypes, genotypes, and macrolide resistance mechanisms of macrolide-inactivating Escherichia coll recovered in Japan from 1996 to 1997, were investigated.
such as clarithromycin and roxithromycin for the treatment of diffuse panbronchiolitis, Helicobacter pylori and Mycobacterium avium complex infections. In this study, the phenotypes, genotypes, and macrolide resistance mechanisms of macrolide-inactivating Escherichia coll recovered in Japan from 1996 to 1997, were investigated.
The isolation rate of erythromycin A highly-resistant E. coli (MIC > 1600 /xg/ml) in Japan slightly increased from 0.5% in 1986 to 1.2% in 1997. In six macrolide-resistant strains, recovered from the strains collected for this study during 1996 to 1997, the inactivation of macrolide could be detected with or without added ATPin the assay system. The appearance of erythromycin A-inactivating enzyme independent of ATPwas novel from Japanese isolates, and the ]H NMRspectra of oleandomycin hydrolyzed by the three ATP-independent isolates were examined. It was clearly shown that the lactone ring at the position of C-13 was cleaved as 13-H signal in aglycon of oleandomycin upper shifted. These results suggested the first detection of macrolide-lactone ring-hydrolase from clinical isolates in Japan. These results suggested the first detection of an ATP-independent macrolide-hydrolyzing enzyme from Japanese clinical isolates. Substrate specificity of the macrolide-hydrolyzing enzyme was determined with twelve macrolides including the newer membersof this group and it was found that not only erythromycin A but also the new macrolides, such as clarithromycin, roxithromycin, and azithromycin were inactivated. The NMRdata, broad spectrum of activity, and independence of co-enzymesupported our namingof the enzymeas a macrolide esterase. PCRmethodology was employed to detect an ereB-like gene from the 3 isolates producing macrolide esterase, and one of these was subsequently shown to contain both ereB-like and ermB-Wksgenes. It was also clearly shown that the other three isolates, which inactivated macrolide in the presence of ATP, had an mphA-liko gene.
Macrolide antibiotics are mainly active against Grampositive bacteria such as Staphylococcus aureus. Acquired resistance to macrolide antibiotics has been extensively studied in these bacteria and is generally due to N6-dimethylation of a specific adenine residue in 23S rRNA1>2).
Members of the family Enterobacteriaceae, like most
Gram-negative organisms, are intrinsically resistant to low levels of erythromycin A, probably by efflux pumps3).
However, higher local antibiotic concentrations of 0.5 to 6mg/g of feces are obtained in the lumen of the intestinal tract after oral absorption of usually recommended therapeutic doses. Enterobacteriaceae highly resistant to erythromycin A (MIC, >500 jUg/ml) can be isolated, after pp.516 -524 oral administration of the drug4). communitywith the development of macrolide-resistant strains of Enterobacteriaceae such as Escherichia coli, because intestinal bacteria were exposed to a significant concentration of macrolide over a long term. The appearance of macrolide resistance among E. coli strains recently isolated in Japan and the phenotypes and genotypes of macrolide highly-resistant strains were investigated in this study.
Materials and Methods

Bacterial Strains
Five hundred clinical isolates ofE. coli were collected at random from 1996 to 1997 in Japan. Three erythromycin A highly-resistant strains producing a macrolide-inactivating enzymewere used as the reference strains. These were MPH (2' ) I-producing E. coli Tf481A7' 8' 14' 15), MPH(2' ) IIproducing E. coli BM25069'10'17), and erythromycin-esterase ATP, 50^1 of each antibiotic (125^g/ml), and 400^1 of the crude extract diluted with TMKbuffer were mixed and allowed to react at 37°C for 0, 0.5, 1, 2, 4, and 18 hours. Over the course of the reaction, a 20^1 aliquot was periodically removed onto a paper disc, heated to stop the reaction, and the residual activity was determined by microbioassay.
Release ofEnzyme from E. coli Cells by Osmotic Shock The release of the enzymefrom E. coli cells by osmotic shock was performed by the modified method8) of Neu and Chou25) with 250 ml of culture. Detection of /3-lactamase, a reference for the release of enzymes in the periplasmic space, was performed by UV spectrometry25) with penicillin G as the substrate.
NMRSpectrometry of Esterase
The NMRspectrometric measurement of the inactivation of macrolide antibiotics by esterase was prepared as follows: 0.1 ml of a suspension of the solution of crude enzyme (600jig of protein), 1 mg of oleandomycin and 0.4ml of 0.1 Mphosphate buffer (pH 7.0) were mixed in a micro centrifuge tube and incubated at 37°C for 0, 1, 2, and 4 hours. The reaction was stopped by heating the mixture at 100°C for 3 minutes. The supernatant was lyophilized after centrifugation of the reaction mixture at 9,000X#, and then dissolved in 0.5ml of deuterium oxide (D2O; Merck, Germany) in an NMRtube (5 mminternal dia.).
The^-NMR spectra were recorded with a highresolution 500MHz Fourier Transform (FT) NMR spectrometer JNM-A500a (JAOL, Tokyo, Japan). The residual 13-H (at 5.34ppm) signal relating to the extent of hydrolysis of the lactone ring of aglycone was integrated.
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The intensity of the signal was compared with that of the 1"-H signal at 5.07ppm of L-oleandrose. The homogenated decoupling mode of the NMR spectrometer was used for suppression of the HOD-signal at 4.78 ppm17~19' 26).
Transfer of Drug Resistance
Transfer of drug resistance was done by mixed cultivation of donor and recipient, either in nutrient broth or on a membrane filter (Type HA, 0.45^m, Nihon Millipore Kogyo K.K., Tokyo, Japan). For the filter mating method, exponentially growing cultures of donor (0.4ml) and recipient (0.4ml) were mixed, and the mixed culture was filtered through the membranefilter28^.
After overnight culture at 37°C on nutrient agar plates containing both 50 jug/ml of rifampicin and 200 /ag/ml of erythromycin A, colonies were counted, and the transfer frequency of drug resistance was determined.
Detection of the Macrolide-inactivating
Enzyme Gene by PCR Methodology Primers for ereA, ereB, mphA, ermA, ermB and ermC were used to provide specific PCRproducts of 420, 546, 837, 645, 639 and 642bp respectively. The detection method was equivalent to that described by Sutcliffe J. et al29\ For these experiments, the ereA primers were 5'-AACACCCTGAACCCAAGGGACG-3 ' and 5 '-CTTCAC-ATCCGGATTCGCTCGA-3', the ereB primers were 5'-AGAAATGGAGGTTCATACTTACCA -3 ' and 5'-CATA-TAATCATCACCAATGGCA-3', the mphA primers were 5'-AACTGTACGCACTTGC-3' and 5'-GGTACTCTTC-GTTACC-3'. the ermA primers were 5'-TCTAAAAA-GCATGTAAAAGAA-3 ' and 5 '-CTTCGATAGTTTATTA-ATATTAGT-3', the ermB primers were 5'-GAAAAG-GTACTCAACCAAATA -3' and 5'-AGTAACGGTACT-TAAATTGTTTAC-3', the ermC primers were 5'-TCA-AAACATAATATAGATAAA-3 ' and 5 ' -GCTAATATTGTT-TAAATCGTCAAT-3 ', respectively. Primers for mphBm3) were specifically designed for this study. The mphBprimers were 5 ' -GCGATAGAATTCAAGGAGAAATAATATGAC-CGTAGTCACGACCGCCGAT-3' (first 14 bases are the restriction enzyme site, next 12 bases represent the ribosome binding site for cloning, and the final 24 bases are from the structural gene) and 5'-GTTTTCCCAGTCA-CGACGTTGT-3'. The Takara LA PCR kit was used as recommended by Takara Syuzo Co., Ltd. Kyoto, Japan, employing 4mMMgCl2 for each primer of the ereA, ereB, mphA, and mphBgenes and 2 mMMgCl2 for each primer of the ermA, ermB, and ermC genes. PCRproducts were detected and distinguished by electrophoresis on 1%
agarose gels in 40 mMTris acetate-2 mMEDTAbuffer. 
Results and Discussion
From the 500 clinical isolates of E. coli which were recovered in Japan during 1996 and 1997, six strains (1.2%) were discovered on subculture to be capable of growth on plates containing 1,600 /ig/ml of erythromycin A.
MICvalues of various macrolides to these erythromycin
A highly-resistant isolates were determined (Table 1) . These six strains were highly resistant to all 14-membered ring macrolides. On the other hand, the resistance pattern to 15-and 16-membered ring macrolides was different and on this basis we classified the six strains into 3 groups consisting of strain M26, strains M44 and Ml60, and strains M377, M499 and M560 respectively.
As an example of the differences, we noted that strain M26 was highly resistant to azithromycin and 16-membered ring macrolides, whereas strains M44and Ml60 519 showed low resistance to 1 6-membered ring macrolides. The inactivation of macrolide antibiotics by the erythromycin A highly-resistant strains was investigated by the LDRmethod using intact cells, LDRsolution and various co-enzymes (ATP, GTP, UDPG, NADP and GSH), upon which the reaction of someantibiotic-inactivating enzymes maybe dependent as previously reported. It was found that three erythromycin A-resistant (MIC: >1,600/ig/ml) strains of E. coli, M26, M44 and Ml60, inactivated oleandomycin under the test conditions, independent of coenzyme. These results suggested that strains M26, M44and Ml60 had a macrolide-inactivating hydrolase, possibly an esterase. as esterases function independently of any coenzymes.
The remaining three of the six highly erythromycin Aresistant strains (M377, M499 and M560), were found to inactivate macrolide in the presence of ATP. Oleandomycin, inactivated oleandomycin produced by erythromycinesterase I from strain BM694/pAT63, and inactivated Selected by erythromycin A (200 jUg/ml) and rifampicin (25 JLLg/ml). Selected by tetracycline (25 /Ig/ml) and rifampicin (25 flg/ml). EM; erythromycin A (200//g/ml), CBPC; carbenicillin (400jUg/ml), TC; tetracycline (25 JUg/ml), GM; gentamicin (25 ug/ml), KM; kanamycin (25 Ug/ml), NFLX; norfloxacin (25 ug/ml), RFP; rifampicin (25 Ug/ml).
oleandomycin from strain M26 were analyzed by !H NMR. The 10-H signal of oleandomycin shifted from 3.41 ppm to 2.07ppm, and the 13-H signal of oleandomycin shifted from 5.32ppm to 4.22ppm, in the NMRspectra of both enzymatically inactivated oleandomycin samples. These changes indicated the cleavage of the lactone ring of oleandomycin. Identical changes were seen in the inactivated oleandomycin produced by strains M44 and Ml60 and these results confirmed that the inactivated oleandomycin from the three strains (M26, M44, and Ml60) was the same as that from the erythromycin esterase I-producing strain BM694/pAT63.The test data indicated that, for the first time, strains producing the macrolidehydrolyzing esterase enzyme had appeared in Japan.
The transfer frequency of the co-enzyme independent macrolide resistant phenotype was investigated by the membrane filter mating method. Macrolide resistance could only be transferred from E. coli M26to recipient strain W31 10rif, and the transconjugant obtained inactivated oleandomycin. Its transfer frequency was 1 X 10~4, which is the same as the transferable plasmid RP4. Transfer was undetectable, being <1 X 10"8, for strains M44 and M160. Strain M26 demonstrated multiple drug-resistance including tetracycline, carbenicillin, kanamycin, gentamicin and norfloxacin ( represented by erythromycin A, but also newer macrolides such as clarithromycin, roxithromycin, and azithromycin. From these results, it was thought that the macrolidehydrolyzing enzyme should be termed a macrolide esterase, rather than an erythromycin esterase. The location of the macrolide esterase in E. coli M26 cells was determined in fractions obtained by the osmotic Fig. 1 . Substrate specificity ofmacrolide-inactivating enzyme. Macrolide (ML)-inactivating activity was measured by determining the amount of remaining oleandomycin in a bioassay. /3-lactamase activity was measured as the inactivation of penicillin G determined by the UVspectrometry method.
a Extracellular enzymefraction.
b Periplasmic-space enzyme fraction.
c Intracellular enzyme fraction shock method (Table 3) . /J-Lactamase in strain M26was used as a reference periplasmic enzyme. The macrolide esterase of E. coli M26was detected in the cold-water fraction (fraction 4), the same as the periplasmic /}-lactamase. Thus, it appeared that macrolide esterase was a periplasmic enzyme. The macrolide esterase gene was detected by PCR carried out with primers of each of the erythromycin esterase I-and erythromycin esterase II-producing genes (ereA and ereB, respectively). PCRproducts from the ereB- Source ofDNA for each lane: lanes 2 and 10, E. coli M26, lanes 3 and ll, is. coli M44, lanes 4 and 12, E. coli M160, lane 5, E. coli Tf481A, lane 7, E. coli M377, lane 8, E. coli M499, lane 9, E. coli M560, lanes 1, 6 and 14, E. coli W3110n/, lane 13, S. aureus 01Al117, M, DNAmakers.
primer were detected in strains M26, M44and Ml60, respectively (Fig. 2) , showing that these macrolide esterase genes had a strong similarity to the ereB-gcnQ. The results supported the conclusion that, for the first time, an ereBlike gene had been detected in Japane and that it had been recovered at a rate of 0.6% from the 500 clinical isolates studied.
In addition, an ermi?-specific PCRproduct was detected from strain M26, but not from the others (M44, Ml60, M377, M499, and M560) (Fig. 2) . Our results indicated that the ere gene and erm gene were present in the same transferable plasmid in strain M26, and one might speculate that both genes mayhave been transported from Europe1!) to Japan. PCRwas also done using probes for the detection of the mphAor mphBgenes. The mphAgene was detected from those three strains, M377, M499 and M560, which were coenzyme dependent and which could inactivate macrolide only in the presence ofATP (Fig. 2 ).
In conclusion, macrolide resistant strains showed a slight increase from 0.5%7) to 1.2% of clinical isolates over a period of about 10 years in Japan. And we detected the appearance of the macrolide esterase enzymein clinical isolates ofE. coli in Japan recovered in 1996 and 1997. The enzyme was characterized by its ability to inactivate the new macrolides such as clarithromycin, roxithromycin and VOL.53 NO. 5 THE JOURNAL OF ANTIBIOTICS azithromycin in the absence of co-enzyme. The ereB and ermBgenes were detected in these strains. In addition, the mphAgene was detected from three strains of E. coli, which elaborated a co-enzyme dependent resistance.
